Search results for “Ataxia telangiectasia mutated” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 90 patents, we discovered top 17 key players by total patent application. AstraZeneca Pharmaceutical Co., Ltd., Maybridge Ltd., Shuttle Pharmaceuticals, Inc. are dominant in this area. They take 67.78% of the total patent filing.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 35
Maybridge Ltd.
CHESHIRE, United Kingdom
Patent: 17
Shuttle Pharmaceuticals, Inc.
United States
Patent: 9
Suzhou Zanrong Pharmaceutical Technology Co. Ltd.
Jiangsu Sheng, China
Patent: 9
Signal Pharmaceuticals LLC
California, United States
Patent: 4
Oncoinvent AS
Oslo, Norway
Patent: 3
BGI Genomics Co., Ltd.
Guangdong Sheng, China
Patent: 2
Baystate Health System Health Services, Inc.
Massachusetts, United States
Patent: 2
Samsung Electronics Co., Ltd.
South Korea
Patent: 1
AstraZeneca PLC
Cambridgeshire, United Kingdom
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Bold Therapeutics, Inc.
British Columbia, Canada
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 25 patents applied in the last 5 years. We discover 9 most active companies in this area. The fast-growing Suzhou Zanrong Pharmaceutical Technology Co. Ltd., AstraZeneca Pharmaceutical Co., Ltd., Oncoinvent AS take 64.00% of patent filing during this period.
Suzhou Zanrong Pharmaceutical Technology Co. Ltd.
Jiangsu Sheng, China
Patent: 9
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 4
Oncoinvent AS
Oslo, Norway
Patent: 3
Shuttle Pharmaceuticals, Inc.
United States
Patent: 2
UAB Research Foundation
Alabama, United States
Patent: 1
Nanjing Leizheng Pharmaceutical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
City of Södertälje (Sweden)
Sweden
Patent: 1
STARTUP
Bold Therapeutics, Inc.
British Columbia, Canada
Patent: 1
Beijing Anngeen Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 25 patents in last 5 years, we discover 7 new entrants. Suzhou Zanrong Pharmaceutical Technology Co. Ltd., Oncoinvent AS, UAB Research Foundation are the most active new entrants in this area.
Suzhou Zanrong Pharmaceutical Technology Co. Ltd.
Jiangsu Sheng, China
Patent: 9
Oncoinvent AS
Oslo, Norway
Patent: 3
UAB Research Foundation
Alabama, United States
Patent: 1
Nanjing Leizheng Pharmaceutical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
City of Södertälje (Sweden)
Sweden
Patent: 1
STARTUP
Bold Therapeutics, Inc.
British Columbia, Canada
Patent: 1
Beijing Anngeen Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 25 patents, we discovered top 6 universities and scientific research institutions by total patent application. Institute Of Cancer Research, Institut Gustave Roussy EURL, The Johns Hopkins University are dominant in this area. They take 60.00% of the total patent filing.
Institute Of Cancer Research
United Kingdom
Patent: 5
Institut Gustave Roussy EURL
France
Patent: 3
The Johns Hopkins University
United States
Patent: 2
University of Massachusetts
Massachusetts, United States
Patent: 1
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 1
Chongqing University
Chongqing Shi, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: